Scopolamine Patch, Extended Release
Product Images NDC 50742-505

14 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 50742-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structuralformula001)

Structure (Structuralformula001)
Chemical structure of scopolamine, showing its bicyclic tropane ring system with an attached epoxide group and a phenylacetate moiety.*
FDA Label Image

System (System001)

System (System001)
A labeled cross-sectional diagram illustrating the layers of a Scopolamine transdermal extended-release patch. From top to bottom, the layers are identified as Backing Membrane, Drug in Adhesive Layer, Rate Controlling Membrane, Drug in Adhesive Layer, and Release Liner.*
FDA Label Image

Logo (Logo01)

Logo (Logo01)
The image shows a white rectangular packaging carton for Scopolamine, a 1.5 mg extended-release transdermal patch. The label features the Ingenus Pharmaceuticals, LLC logo in black and gray at the top left corner. There are no additional visible text details on the carton front shown.*
FDA Label Image

Image Description (Figure01)

Image Description (Figure01)
An illustration diagram of a Scopolamine 1 mg extended-release transdermal patch showing its clear disposable plastic release liner with stipples, metallic adhesive surface, and tan backing membrane printed with the text 'Scopolamine 1 mg/3 days.'*
FDA Label Image

Image Description (Figure2)

Image Description (Figure2)
An instructional diagram showing how to open the pouch of the Scopolamine transdermal patch by tearing along the dashed lines.*
FDA Label Image

Image Description (Figure003)

Image Description (Figure003)
An instructional illustration showing two hands peeling apart the layers of a transdermal patch, revealing its inner adhesive side. This diagram likely demonstrates how to properly remove the protective backing of the patch before application.*
FDA Label Image

Image Description (Figure4)

Image Description (Figure4)
An instructional diagram showing a person peeling the clear, disposable plastic release liner with stipples off a scopolamine transdermal patch. The patch features an imprinted tan-colored transdermal system and a metallic adhesive surface.*
FDA Label Image

Image Description (Figure5)

Image Description (Figure5)
An instructional illustration depicting the placement of a Scopolamine 1.5 mg extended-release transdermal patch behind the ear on the side of the head. The diagram points to the patch, labeled as an "imprinted tan-colored transdermal system."*
FDA Label Image

Logo (Logo02)

FDA Label Image

1 Patch Front (Image01)

1 Patch Front (Image01)
Packaging label for Scopolamine Transdermal System by Ingenus Pharmaceuticals, showing a strength of 1 mg for 3 days. The label includes usage warnings, an illustration of ear placement, the NDC 50742-505-01, and indicates the package contains one transdermal system patch. Prescription only.*
FDA Label Image

1 Patch Back (Image02)

1 Patch Back (Image02)
This image shows the packaging label text for Scopolamine 1.5 mg transdermal patch by Ingenus Pharmaceuticals. It contains directions for use, dosage administration instructions, inactive ingredients, storage conditions, and safety warnings including to keep out of reach of children and not to use if the seal is broken. The label also includes manufacturing details and a barcode.*
FDA Label Image

4 Patches (Image003)

4 Patches (Image003)
Scopolamine Transdermal System 1 mg/3 days patch packaging label from Ingenus Pharmaceuticals, LLC. The box indicates a 4 transdermal systems multipack with a formulated delivery of approximately 1 mg over three days. Directions, caution, and manufacturing details appear on the back panel along with NDC 50742-505-04 and barcode.*
FDA Label Image

10 Patches (Image04)

10 Patches (Image04)
Scopolamine Transdermal System 1 mg/3 days patch packaging multipack by Ingenus Pharmaceuticals, LLC. The label indicates a 10 transdermal systems multipack with formulated delivery of approximately 1 mg over three days. Instructions for use, caution statements, and storage information are provided on the packaging.*
FDA Label Image

24 Patches (Image05)

24 Patches (Image05)
Packaging label for Scopolamine Transdermal System 1 mg/3 days, a human prescription transdermal patch by Ingenus Pharmaceuticals, LLC. The label states the product delivers approximately 1 mg over three days and includes 24 transdermal systems in a multipack. The label includes dosing instructions, cautionary statements, and barcodes for product identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.